Andrew Fein
Stock Analyst at HC Wainwright & Co.
(3.66)
# 769
Out of 4,944 analysts
598
Total ratings
45.02%
Success rate
7.82%
Average return
Main Sectors:
Stocks Rated by Andrew Fein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIIB Biogen | Maintains: Buy | $187 → $194 | $128.93 | +50.47% | 22 | Aug 1, 2025 | |
| UTHR United Therapeutics | Maintains: Buy | $425 → $400 | $301.39 | +32.72% | 16 | Jul 31, 2025 | |
| FULC Fulcrum Therapeutics | Upgrades: Buy | $4 → $12 | $6.54 | +83.49% | 18 | Jul 29, 2025 | |
| KALV KalVista Pharmaceuticals | Reiterates: Buy | $27 | $12.25 | +120.41% | 16 | Jul 11, 2025 | |
| CADL Candel Therapeutics | Assumes: Buy | $23 | $6.35 | +262.20% | 1 | Jun 30, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $54 → $60 | $39.87 | +50.49% | 8 | Jun 26, 2025 | |
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $32 | $25.45 | +25.74% | 20 | Jun 26, 2025 | |
| VRTX Vertex Pharmaceuticals | Reiterates: Buy | $550 | $387.77 | +41.84% | 27 | Jun 23, 2025 | |
| INSM Insmed | Maintains: Buy | $90 → $120 | $122.00 | -1.64% | 15 | Jun 11, 2025 | |
| PEPG PepGen | Maintains: Buy | $14 → $8 | $1.14 | +601.75% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $6 → $2 | $2.58 | -22.48% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $35 | $24.10 | +45.23% | 14 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $14 | $7.54 | +85.68% | 18 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $35 | $13.53 | +158.68% | 14 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $14 | $2.44 | +473.77% | 15 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $18.74 | +300.21% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $68 | $46.23 | +47.09% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $10 | $2.00 | +400.00% | 10 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $38 | $11.64 | +226.60% | 12 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $16 | $8.20 | +95.12% | 20 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $25 | $13.72 | +82.22% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $32 | $13.22 | +142.06% | 22 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $8.35 | +259.28% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $16 | $9.81 | +63.10% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $24 | $6.80 | +253.20% | 19 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $2.15 | +458.14% | 16 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $43.11 | -11.84% | 6 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.47 | +223.89% | 2 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $168 | $128.89 | +30.34% | 20 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $3.85 | +81.82% | 13 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $11 | $1.26 | +773.02% | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.41 | +609.22% | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $8.45 | +160.36% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 → $2 | $0.78 | +155.20% | 16 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $1.91 | +528.27% | 12 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $4.87 | +166.94% | 14 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $7.48 | +47.06% | 10 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $3.07 | +649.19% | 14 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.67 | +798.20% | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $63.76 | +33.31% | 16 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $20.34 | +72.07% | 14 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $8.96 | +737.05% | 7 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $24.98 | +200.24% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $2.24 | +212.50% | 6 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $5.00 | +100.11% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $40 | $4.79 | +735.07% | 3 | Feb 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $1.48 | +10,035.14% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $200 → $60 | $14.88 | +303.23% | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $5.36 | +179.85% | 1 | Apr 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $40 | $1.70 | +2,252.94% | 3 | Mar 16, 2022 |
Biogen
Aug 1, 2025
Maintains: Buy
Price Target: $187 → $194
Current: $128.93
Upside: +50.47%
United Therapeutics
Jul 31, 2025
Maintains: Buy
Price Target: $425 → $400
Current: $301.39
Upside: +32.72%
Fulcrum Therapeutics
Jul 29, 2025
Upgrades: Buy
Price Target: $4 → $12
Current: $6.54
Upside: +83.49%
KalVista Pharmaceuticals
Jul 11, 2025
Reiterates: Buy
Price Target: $27
Current: $12.25
Upside: +120.41%
Candel Therapeutics
Jun 30, 2025
Assumes: Buy
Price Target: $23
Current: $6.35
Upside: +262.20%
Kymera Therapeutics
Jun 26, 2025
Maintains: Buy
Price Target: $54 → $60
Current: $39.87
Upside: +50.49%
ACADIA Pharmaceuticals
Jun 26, 2025
Reiterates: Buy
Price Target: $32
Current: $25.45
Upside: +25.74%
Vertex Pharmaceuticals
Jun 23, 2025
Reiterates: Buy
Price Target: $550
Current: $387.77
Upside: +41.84%
Insmed
Jun 11, 2025
Maintains: Buy
Price Target: $90 → $120
Current: $122.00
Upside: -1.64%
PepGen
May 29, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $1.14
Upside: +601.75%
May 29, 2025
Downgrades: Neutral
Price Target: $6 → $2
Current: $2.58
Upside: -22.48%
May 28, 2025
Maintains: Buy
Price Target: $29 → $35
Current: $24.10
Upside: +45.23%
May 27, 2025
Maintains: Buy
Price Target: $30 → $14
Current: $7.54
Upside: +85.68%
May 14, 2025
Maintains: Buy
Price Target: $47 → $35
Current: $13.53
Upside: +158.68%
May 14, 2025
Maintains: Buy
Price Target: $20 → $14
Current: $2.44
Upside: +473.77%
May 12, 2025
Maintains: Buy
Price Target: $80 → $75
Current: $18.74
Upside: +300.21%
May 12, 2025
Maintains: Buy
Price Target: $72 → $68
Current: $46.23
Upside: +47.09%
May 9, 2025
Maintains: Buy
Price Target: $7 → $10
Current: $2.00
Upside: +400.00%
May 9, 2025
Maintains: Buy
Price Target: $46 → $38
Current: $11.64
Upside: +226.60%
May 9, 2025
Maintains: Buy
Price Target: $12 → $16
Current: $8.20
Upside: +95.12%
May 8, 2025
Maintains: Buy
Price Target: $40 → $25
Current: $13.72
Upside: +82.22%
May 7, 2025
Maintains: Buy
Price Target: $80 → $32
Current: $13.22
Upside: +142.06%
May 6, 2025
Reiterates: Buy
Price Target: $30
Current: $8.35
Upside: +259.28%
May 5, 2025
Maintains: Buy
Price Target: $7 → $16
Current: $9.81
Upside: +63.10%
May 2, 2025
Maintains: Buy
Price Target: $81 → $24
Current: $6.80
Upside: +253.20%
May 1, 2025
Maintains: Buy
Price Target: $16 → $12
Current: $2.15
Upside: +458.14%
Apr 30, 2025
Reiterates: Buy
Price Target: $38
Current: $43.11
Upside: -11.84%
Apr 28, 2025
Reiterates: Buy
Price Target: $8
Current: $2.47
Upside: +223.89%
Apr 22, 2025
Maintains: Buy
Price Target: $185 → $168
Current: $128.89
Upside: +30.34%
Apr 4, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $3.85
Upside: +81.82%
Mar 28, 2025
Maintains: Buy
Price Target: $15 → $11
Current: $1.26
Upside: +773.02%
Mar 27, 2025
Reiterates: Buy
Price Target: $10
Current: $1.41
Upside: +609.22%
Mar 26, 2025
Reiterates: Buy
Price Target: $22
Current: $8.45
Upside: +160.36%
Mar 17, 2025
Downgrades: Neutral
Price Target: $12 → $2
Current: $0.78
Upside: +155.20%
Mar 14, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $1.91
Upside: +528.27%
Mar 7, 2025
Reiterates: Buy
Price Target: $13
Current: $4.87
Upside: +166.94%
Mar 6, 2025
Reiterates: Buy
Price Target: $11
Current: $7.48
Upside: +47.06%
Mar 6, 2025
Reiterates: Buy
Price Target: $23
Current: $3.07
Upside: +649.19%
Mar 6, 2025
Reiterates: Buy
Price Target: $15
Current: $1.67
Upside: +798.20%
Mar 3, 2025
Reiterates: Buy
Price Target: $85
Current: $63.76
Upside: +33.31%
Feb 28, 2025
Reiterates: Buy
Price Target: $35
Current: $20.34
Upside: +72.07%
Feb 18, 2025
Reiterates: Buy
Price Target: $75
Current: $8.96
Upside: +737.05%
Jan 13, 2025
Reiterates: Buy
Price Target: $75
Current: $24.98
Upside: +200.24%
Nov 2, 2023
Maintains: Buy
Price Target: $17 → $7
Current: $2.24
Upside: +212.50%
Aug 15, 2023
Reiterates: Buy
Price Target: $10
Current: $5.00
Upside: +100.11%
Feb 13, 2023
Maintains: Buy
Price Target: $100 → $40
Current: $4.79
Upside: +735.07%
Jan 31, 2023
Reiterates: Buy
Price Target: $150
Current: $1.48
Upside: +10,035.14%
May 5, 2022
Downgrades: Neutral
Price Target: $200 → $60
Current: $14.88
Upside: +303.23%
Apr 27, 2022
Assumes: Buy
Price Target: $15
Current: $5.36
Upside: +179.85%
Mar 16, 2022
Maintains: Neutral
Price Target: $80 → $40
Current: $1.70
Upside: +2,252.94%